Ekstrand J, Björkman L, Edlund C, Sandborgh-Englund G
Department of Basic Oral Sciences, Faculty of Dentistry, Karolinska Institutet, Huddinge, Sweden.
Eur J Oral Sci. 1998 Apr;106(2 Pt 2):678-86. doi: 10.1046/j.0909-8836.1998.eos10602ii03.x.
This paper summarizes some recent reports on mercury release from amalgam fillings and resulting concentrations in biological fluids, development of antibiotic resistance, and kidney function. In a series of studies of subjects with amalgam fillings, mercury (Hg) levels were followed in saliva, feces, blood, plasma, and urine before and until 60 d after removal of all of the fillings. The Hg concentrations in saliva remained elevated for at least 1 wk, suggesting that dissolved Hg vapor is not the major source of mercury in mixed saliva. An absorption phase of Hg was seen in plasma during 24 h after amalgam removal. After 60 d the plasma Hg concentration was reduced to 40%, of the baseline level. The decrease per amalgam surface was 0.11 nmol/l (range 0.02 0.40). The Hg level in feces increased two orders of magnitude two days after amalgam removal. At day 60, the median Hg concentration was still slightly higher than the median value of the amalgam free control group. The resistance patterns of the oral and intestinal microflora in these subjects were also studied. In the intestinal microflora, the relative amount of intestinal microorganisms resistant to 50 microM HgCl2 peaked 7 d after removal of the amalgam fillings, with a median value per sample of 6.1%, compared to 1.3% in samples collected prior to the Hg exposure. However, no statistical differences in the resistance pattern of the oral microflora were detected between the control and the experimental groups. A number of sensitive kidney function parameters were measured 1 wk before and 1, 2, and 60 d after amalgam removal. No effects on the various kidney parameters studied were recorded. According to the conclusions of independent evaluations from different state health agencies, the release of mercury from dental amalgam does not present any non-acceptable risk to the general population.
本文总结了近期一些关于汞合金填充物释放汞及其在生物体液中的浓度、抗生素耐药性的发展以及肾功能的报告。在一系列针对有汞合金填充物受试者的研究中,在移除所有填充物之前以及之后直至60天,对唾液、粪便、血液、血浆和尿液中的汞(Hg)水平进行了跟踪监测。唾液中的汞浓度至少持续1周升高,这表明溶解的汞蒸气不是混合唾液中汞的主要来源。在移除汞合金填充物后的24小时内,血浆中出现了汞的吸收阶段。60天后,血浆汞浓度降至基线水平的40%。每个汞合金表面的下降量为0.11纳摩尔/升(范围为0.02至0.40)。汞合金移除两天后,粪便中的汞水平增加了两个数量级。在第60天,汞浓度中位数仍略高于无汞合金对照组的中位数。还研究了这些受试者口腔和肠道微生物群的耐药模式。在肠道微生物群中,对50微摩尔氯化汞有抗性的肠道微生物相对数量在移除汞合金填充物后7天达到峰值,每个样本的中位数为6.1%,而在汞暴露前采集的样本中为1.3%。然而,在对照组和实验组之间未检测到口腔微生物群耐药模式的统计学差异。在移除汞合金填充物前1周以及移除后1天、2天和60天,测量了一些敏感的肾功能参数。未记录到对所研究的各种肾脏参数有影响。根据不同州卫生机构的独立评估结论,牙科汞合金释放的汞对普通人群不存在任何不可接受的风险。